多瑞医药：关于成立全资子公司的公告

Core Viewpoint - Duori Pharmaceutical announced the establishment of a wholly-owned subsidiary, Tibet Ruishengxiang Pharmaceutical Co., Ltd., to optimize its headquarters management functions in response to operational and strategic development needs [2] Group 1 - The establishment of the subsidiary is part of the company's strategy to enhance management efficiency [2] - The new subsidiary is expected to support the company's overall operational goals [2]